US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Respiratory/Pulmonary Market Research Reports & Industry Analysis

RSS Feeds

Respiratory/Pulmonary Industry Research & Market Reports

1    3    5  6  7  8  9  10  
Acute Bronchitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Small-Cell Lung Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
Respiratory Depression-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Respiratory Depression. This report provides information on the therapeutic development based on the Respiratory Depression dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Bronchospasm- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. ...  |  read more...
USD 2,000
Pulmonary Arterial Hypertension- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
Respiratory Tract Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
Upper Respiratory Tract Infections - Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III ...  |  read more...
USD 2,000
Acute Upper Respiratory Tract Infections Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III ...  |  read more...
USD 2,000
Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... of the report is to establish the understanding for all the pipeline drugs that fall under Cystic Fibrosis Transmembrane Conductance Regulators (CFTR). This report provides information on the therapeutic development based on the Cystic Fibrosis ...  |  read more...
USD 1,250
Respiratory Distress Syndrome-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... all the pipeline drugs that fall under Respiratory Distress Syndrome. This report provides information on the therapeutic development based on the Respiratory Distress Syndrome dealing with all the pipeline drugs, comparative analysis at various stages ...  |  read more...
USD 1,250
Ventilator Associated Pneumonia (VAP)-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... understanding for all the pipeline drugs that fall under Ventilator Associated Pneumonia (VAP). This report provides information on the therapeutic development based on the Ventilator Associated Pneumonia (VAP) dealing with all the pipeline drugs, comparative ...  |  read more...
USD 1,250
Pulmonary Embolism - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... therapeutic development for Pulmonary Embolism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Emphysema Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. ...  |  read more...
USD 2,000
Respiratory Hypersensitivity Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Respiratory Syncytial Virus (RSV) Infections Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III ...  |  read more...
USD 2,000
Acute Lung Injury-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... all the pipeline drugs that fall under Acute Lung Injury. This report provides information on the therapeutic development based on the Acute Lung Injury dealing with all the pipeline drugs, comparative analysis at various stages ...  |  read more...
USD 1,250
Acute Respiratory Distress Syndrome-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... understanding for all the pipeline drugs that fall under Acute Respiratory Distress Syndrome. This report provides information on the therapeutic development based on the Acute Respiratory Distress Syndrome dealing with all the pipeline drugs, comparative ...  |  read more...
USD 1,250
Lung Cancer Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... of lung cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors lung cancer technology. These deals tend to ...  |  read more...
USD 995
Cystic Fibrosis Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... deals Top cystic fibrosis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Cystic Fibrosis Partnering 2009-2014 provides understanding and access to the cystic fibrosis partnering deals and agreements ...  |  read more...
USD 695
Pneumonia Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Pneumonia Partnering 2009-2014 provides understanding and access to the pneumonia partnering deals and agreements entered into by the worlds ...  |  read more...
USD 695
Acute Lung Injury Global Clinical Trials Review, H2, 2014
10/31/2014 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Acute Lung Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
USD 2,500
Lung Transplantation Global Clinical Trials Review, H2, 2014
10/31/2014 | published by: GlobalData
... information and data relating to the clinical trials on Lung Transplantation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Cystic Fibrosis Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Cystic Fibrosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Pulmonary Hypertension Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Pulmonary Hypertension in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Respiratory Disorders Pipeline Highlights Database – 2015
11/5/2014 | published by: Fore Pharma
... Respiratory Disorders in active clinical development stages including early and late stage clinical trials. Key indications covered in this report include Chronic obstructive pulmonary disease, Sinusitis (Acute and Chronic), Asthma, Bronchitis (Acute and Chronic). The ...  |  read more...
USD 2,800
1    3    5  6  7  8  9  10